S. Zaveri Pharmakem's Distribution Business was Acquired by Azelis India

▴ S. Zaveri Pharmakem's
Azelis India's presence will be shown in the India's Pharmaceutical market as they are acquiring the distribution business of S.Zaveri Pharmakem, India.

S.Zaveri Pharmakem established in 1951, is one of the India's leading supplier of pharmaceutical raw materials and chemicals, happilly announced that their distribution business was completely acquired by Azelis India. With this association both the companies will be benefitted in the pharmacuticals market of India.

Ms Uma Javeri MD of S.Zaveri Pharmachem said, "Becoming part of such a reputable and big international player will not only provide continuity and security of our distribution business but also additional expertise, infrastructure and growth opportunities. All of those are very important to us and we are thrilled about the next phase in our company history. We have known Azelis for a while, we have great respect for one another, our values and ethos are shared so we are convinced that this was the right move.”

Laurent Nataf, CEO & President, Azelis Asia Pacific, said, “The Indian pharmaceutical industry has grown dramatically over the last 20 years, making it one of the most established exporters of pharmaceuticals, particularly generics. This growth is projected to continue both domestically and internationally. Establishing a strong presence in the pharmaceutical market in India is therefore essential for a distributor like Azelis and we are very excited to have found such a good partner, which will serve as a very good platform to further expand our pharma activities in India. S Zhaveri has an excellent reputation in the market, a unique set of principals and a very knowledgeable team with strong expertise in excipients.”

“Azelis and S. Zhaveri’s distribution businesses are highly complementary. The Indian excipient market is outpacing the global growth rate. Here in India, we have favourable raw materials and labour environment coupled with quick adaptability of suppliers to new technology, which makes us a perfect and thriving ground for the industry. An acquisition in the pharma business is, therefore, a significant move for us. We expect that the addition of S. Zhaveri will help us strengthen the relationship with some of our strategic principals and open up many new opportunities.” Ms Aparna Khurana, MD of Azelis India Adds.

Tags : #azelis #india #szaveri #pharma #distribution #business #medicircle

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Sexual wellness superstore, Love Depot launches digital campaign to deliver every desireMarch 28, 2024
Recharge Your Life: Simple Ways to Boost Your Physical and Mental EnergyMarch 28, 2024
The Neurological Toll of Common Household Chemicals: Insights from Recent ResearchMarch 28, 2024
The Aging Puzzle: Decoding the Mechanisms of AgingMarch 28, 2024
The Double-Edged Sword of Kala-azar Treatment: Shedding Light on Eye ComplicationsMarch 28, 2024
FTCCI Launches Industry-Academia Connect to improve the employability of Engineering Graduates and address the growing demand for Talent in Emerging TechMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy SystemMarch 27, 2024
2nd Edition of IIFL JITO Ahimsa Run for peace & for non-violence to be held on 31st MarchMarch 27, 2024
Brij Hotels Announced 4 Million in Series A Funding March 27, 2024
Combatting Childhood Sedentariness: The Key to Preventing Premature Vascular DamageMarch 27, 2024
Crucial Findings: Unlocking Paths to Combat Ebola's DevastationMarch 27, 2024
Guarding Against Disease: The Crucial Role of Oral Hygiene in Preventive HealthcareMarch 27, 2024
Sanofi & Cipla announce exclusive distribution partnership to expand reach of CNS portfolio in IndiaMarch 26, 2024
Surmandal's Tribute to the Legends of Hindustani Classical MusicMarch 26, 2024
In Moscow, over 350,000 mammograms have been analyzed using artificial intelligence as part of the compulsory health insurance programMarch 26, 2024
Embark on a Creative Journey: "Kala For A Cause" Unveils Pottery Workshop Series March 26, 2024
Healthtech pioneer Aurora Innovation appoints new CEO – expands in Europe with service that streamlines patient-healthcare interactionMarch 26, 2024
In A Rare Feat, 45 YO Woman Walks Within 6 Hrs. Of Dual Robotic Surgery In A Single Operation At HCGMCCMarch 26, 2024
Improve Cancer Care through Automated CT Analysis: Oncoshield – CTMarch 26, 2024